US › Healthcare

PureTech Health PLC (PRTC)

US · Healthcare · Biotechnology

$17.38+4.51%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$2.8M
Revenue YoY
+1466.6%
Net profit
$-64.9M
Profit YoY
-60.7%
EPS
$0.00
EPS estimate
$0.00
Net margin
-2,319.6%

Key statistics

Market cap
$424.0M
Forward P/E
0.0
P/B
1.26
Book value
$12.91
EPS (TTM)
$-4.60
52-week high
$19.92
52-week low
$14.50
50-day MA
$16.94
200-day MA
$17.21
Beta
0.79

Analyst view

Analysts rate PureTech Health PLC a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $46.00.

Shareholding

Institutions
0.58%

Largest institutional holders

FundStake
Pentwater Capital Management LP0.29%
Millennium Management LLC0.24%
Diadema Partners LP0.03%
Persistent Asset Partners Limited0.01%
UBS Group AG0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for PureTech Health PLC — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.